Vaccines

Ursula von der Leyen has always left a trail of disaster

The German Army had to join a NATO exercise with broomsticks because they didn’t have any rifles. It’s special forces became a hotbed for right-wing extremism. Working mothers were meant to get federally-funded childcare, to help fix the country’s demographic collapse, but it never arrived, and the birth rate carried on falling. Every child was supposed to get a hot lunch at school every day, but somehow or other it didn’t quite happen. There is a common thread running through the career of Ursula von der Leyen, the President of the European Commission. A series of catastrophic misjudgements, and a failure to deliver. In a brutal examination of her record

The EU's vaccine opportunism will not be forgotten

At first, it sounded like empty rage. The European Union had spent all week making wild statements about controlling vaccine exports — even challenging the notion of contract law. On Friday, it has started to act on its words and announced it will introduce controls on vaccines made in the EU — potentially giving itself the power to stop Pfizer sending Britain the vaccines it has paid for. Worse, when it made the announcement, it included Northern Ireland. The EU was set to use the ‘last resort’ mechanism in the recently-agreed Northern Ireland Protocol, Article 16, that can unilaterally impose a land border: something both the UK and EU spent years trying to

Could this drug offer immediate protection from Covid-19?

When Donald Trump returned to the White House after a brief spell in hospital with Covid-19 last October he made a video attributing his rapid recovery to a drug he called ‘Regeneron’. ‘They call it a therapeutic drug, but to me it wasn’t therapeutic – it made me better,’ he said. ‘I call that a cure.’ Naturally, given that Trump had on a previous occasion appeared to advocate injecting humans with disinfectant, there was an element of scepticism on the part of many viewers. However, the drug he was talking about went on the receive emergency use authorisation in November from the US Food and Drug Administration. We now have

Controlling borders is a critical step in the fight against Covid

Over the last two months our fight against Covid-19 appears to have changed dramatically. The emergence of novel variants in the UK, South Africa and Brazil has generated plenty of headlines and concern. We shouldn’t panic. But one thing is clear: if we don’t act now, we could come to regret it. In the UK, for obvious reason we have been most focused on the B.1.1.7 variant. The evidence seems pretty clear that it is more transmissible and potentially more severe. Part of the reason we have such extensive data on virus mutations in the UK is the quite astonishing efforts that have gone into sequencing the viral genomes. With

Can Boris hit his vaccine target?

The government has failed to meet so many Covid-related targets so far that many will be extremely sceptical of the Prime Minister’s pledge on Monday evening to get the over-70s, front-line care workers and vulnerable people of all ages vaccinated by the middle of February. That is around 13 million first doses which will have to be delivered over the next six weeks – compared with just over a million which have been administered since the Pfizer vaccination programme began four weeks ago. We now have the AstraZeneca vaccine as well as the Pfizer one, but can the NHS really increase the rate of vaccination tenfold, as would be necessary to